Global Electrostatic Live Cell Encapsulation Market Research Report 2023

Publication ID:

PB510235095

Publication Date:

October 17, 2023

Pages:

100

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Live cell encapsulation has long been proposed as a solution to many therapeutic problems in modern medicine. Cell encapsulation technology is used to immobilise cells within biocompatible and semipermeable membranes. Encapsulation of cells, rather than therapeutic products, is used to allow the delivery of molecules of interest for a longer time period because cells release these molecules of interest continuously. Furthermore, cells can be engineered to express the desired protein in vivo without modifying the host's genome. Cell encapsulation has a significant advantage over protein encapsulation because it allows for the sustained and controlled delivery of therapeutic molecules at a constant rate, resulting in higher physiological concentrations.
The global Electrostatic Live Cell Encapsulation market is projected to reach US$ 395.5 million in 2029, increasing from US$ 297 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Electrostatic Live Cell Encapsulation 91制片厂.
Key companies engaged in the Electrostatic Live Cell Encapsulation industry include ViaCyte, MIKROCAPS, Balchem Inc, Sernova Corp, Blacktrace Holdings Limited, Merck KGaA, B脺CHI Labortechnik AG, PharmaCyte Biotech and Living Cell Technologies Limited, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Electrostatic Live Cell Encapsulation were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Electrostatic Live Cell Encapsulation market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Electrostatic Live Cell Encapsulation market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
ViaCyte
MIKROCAPS
Balchem Inc
Sernova Corp
Blacktrace Holdings Limited
Merck KGaA
B脺CHI Labortechnik AG
PharmaCyte Biotech
Living Cell Technologies Limited
Sigilon Therapeutics, Inc
Encapsys, LLC
Neurotech LLC
LycoRed Ltd
Beta-O2 Technologies Ltd
DuPont
Austrianova
Segment by Type
Alginate
HEMA-MMA
Chitosan
Siliceous Encapsulates
Cellulose Sulfate
PAN-PVC
Other
Segment by Application
Pharmacy
Regenerative Medicine
Cell Transplantation
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Electrostatic Live Cell Encapsulation report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Electrostatic Live Cell Encapsulation Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Alginate
1.2.3 HEMA-MMA
1.2.4 Chitosan
1.2.5 Siliceous Encapsulates
1.2.6 Cellulose Sulfate
1.2.7 PAN-PVC
1.2.8 Other
1.3 Market by Application
1.3.1 Global Electrostatic Live Cell Encapsulation Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmacy
1.3.3 Regenerative Medicine
1.3.4 Cell Transplantation
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Electrostatic Live Cell Encapsulation Market Perspective (2018-2029)
2.2 Electrostatic Live Cell Encapsulation Growth Trends by Region
2.2.1 Global Electrostatic Live Cell Encapsulation Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Electrostatic Live Cell Encapsulation Historic Market Size by Region (2018-2023)
2.2.3 Electrostatic Live Cell Encapsulation Forecasted Market Size by Region (2024-2029)
2.3 Electrostatic Live Cell Encapsulation Market Dynamics
2.3.1 Electrostatic Live Cell Encapsulation Industry Trends
2.3.2 Electrostatic Live Cell Encapsulation Market Drivers
2.3.3 Electrostatic Live Cell Encapsulation Market Challenges
2.3.4 Electrostatic Live Cell Encapsulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Electrostatic Live Cell Encapsulation Players by Revenue
3.1.1 Global Top Electrostatic Live Cell Encapsulation Players by Revenue (2018-2023)
3.1.2 Global Electrostatic Live Cell Encapsulation Revenue Market Share by Players (2018-2023)
3.2 Global Electrostatic Live Cell Encapsulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Electrostatic Live Cell Encapsulation Revenue
3.4 Global Electrostatic Live Cell Encapsulation Market Concentration Ratio
3.4.1 Global Electrostatic Live Cell Encapsulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Electrostatic Live Cell Encapsulation Revenue in 2022
3.5 Electrostatic Live Cell Encapsulation Key Players Head office and Area Served
3.6 Key Players Electrostatic Live Cell Encapsulation Product Solution and Service
3.7 Date of Enter into Electrostatic Live Cell Encapsulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Electrostatic Live Cell Encapsulation Breakdown Data by Type
4.1 Global Electrostatic Live Cell Encapsulation Historic Market Size by Type (2018-2023)
4.2 Global Electrostatic Live Cell Encapsulation Forecasted Market Size by Type (2024-2029)
5 Electrostatic Live Cell Encapsulation Breakdown Data by Application
5.1 Global Electrostatic Live Cell Encapsulation Historic Market Size by Application (2018-2023)
5.2 Global Electrostatic Live Cell Encapsulation Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Electrostatic Live Cell Encapsulation Market Size (2018-2029)
6.2 North America Electrostatic Live Cell Encapsulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Electrostatic Live Cell Encapsulation Market Size by Country (2018-2023)
6.4 North America Electrostatic Live Cell Encapsulation Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Electrostatic Live Cell Encapsulation Market Size (2018-2029)
7.2 Europe Electrostatic Live Cell Encapsulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Electrostatic Live Cell Encapsulation Market Size by Country (2018-2023)
7.4 Europe Electrostatic Live Cell Encapsulation Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Electrostatic Live Cell Encapsulation Market Size (2018-2029)
8.2 Asia-Pacific Electrostatic Live Cell Encapsulation Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Electrostatic Live Cell Encapsulation Market Size by Region (2018-2023)
8.4 Asia-Pacific Electrostatic Live Cell Encapsulation Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Electrostatic Live Cell Encapsulation Market Size (2018-2029)
9.2 Latin America Electrostatic Live Cell Encapsulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Electrostatic Live Cell Encapsulation Market Size by Country (2018-2023)
9.4 Latin America Electrostatic Live Cell Encapsulation Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Electrostatic Live Cell Encapsulation Market Size (2018-2029)
10.2 Middle East & Africa Electrostatic Live Cell Encapsulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Electrostatic Live Cell Encapsulation Market Size by Country (2018-2023)
10.4 Middle East & Africa Electrostatic Live Cell Encapsulation Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ViaCyte
11.1.1 ViaCyte Company Detail
11.1.2 ViaCyte Business Overview
11.1.3 ViaCyte Electrostatic Live Cell Encapsulation Introduction
11.1.4 ViaCyte Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.1.5 ViaCyte Recent Development
11.2 MIKROCAPS
11.2.1 MIKROCAPS Company Detail
11.2.2 MIKROCAPS Business Overview
11.2.3 MIKROCAPS Electrostatic Live Cell Encapsulation Introduction
11.2.4 MIKROCAPS Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.2.5 MIKROCAPS Recent Development
11.3 Balchem Inc
11.3.1 Balchem Inc Company Detail
11.3.2 Balchem Inc Business Overview
11.3.3 Balchem Inc Electrostatic Live Cell Encapsulation Introduction
11.3.4 Balchem Inc Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.3.5 Balchem Inc Recent Development
11.4 Sernova Corp
11.4.1 Sernova Corp Company Detail
11.4.2 Sernova Corp Business Overview
11.4.3 Sernova Corp Electrostatic Live Cell Encapsulation Introduction
11.4.4 Sernova Corp Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.4.5 Sernova Corp Recent Development
11.5 Blacktrace Holdings Limited
11.5.1 Blacktrace Holdings Limited Company Detail
11.5.2 Blacktrace Holdings Limited Business Overview
11.5.3 Blacktrace Holdings Limited Electrostatic Live Cell Encapsulation Introduction
11.5.4 Blacktrace Holdings Limited Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.5.5 Blacktrace Holdings Limited Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Detail
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Electrostatic Live Cell Encapsulation Introduction
11.6.4 Merck KGaA Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.6.5 Merck KGaA Recent Development
11.7 B脺CHI Labortechnik AG
11.7.1 B脺CHI Labortechnik AG Company Detail
11.7.2 B脺CHI Labortechnik AG Business Overview
11.7.3 B脺CHI Labortechnik AG Electrostatic Live Cell Encapsulation Introduction
11.7.4 B脺CHI Labortechnik AG Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.7.5 B脺CHI Labortechnik AG Recent Development
11.8 PharmaCyte Biotech
11.8.1 PharmaCyte Biotech Company Detail
11.8.2 PharmaCyte Biotech Business Overview
11.8.3 PharmaCyte Biotech Electrostatic Live Cell Encapsulation Introduction
11.8.4 PharmaCyte Biotech Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.8.5 PharmaCyte Biotech Recent Development
11.9 Living Cell Technologies Limited
11.9.1 Living Cell Technologies Limited Company Detail
11.9.2 Living Cell Technologies Limited Business Overview
11.9.3 Living Cell Technologies Limited Electrostatic Live Cell Encapsulation Introduction
11.9.4 Living Cell Technologies Limited Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.9.5 Living Cell Technologies Limited Recent Development
11.10 Sigilon Therapeutics, Inc
11.10.1 Sigilon Therapeutics, Inc Company Detail
11.10.2 Sigilon Therapeutics, Inc Business Overview
11.10.3 Sigilon Therapeutics, Inc Electrostatic Live Cell Encapsulation Introduction
11.10.4 Sigilon Therapeutics, Inc Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.10.5 Sigilon Therapeutics, Inc Recent Development
11.11 Encapsys, LLC
11.11.1 Encapsys, LLC Company Detail
11.11.2 Encapsys, LLC Business Overview
11.11.3 Encapsys, LLC Electrostatic Live Cell Encapsulation Introduction
11.11.4 Encapsys, LLC Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.11.5 Encapsys, LLC Recent Development
11.12 Neurotech LLC
11.12.1 Neurotech LLC Company Detail
11.12.2 Neurotech LLC Business Overview
11.12.3 Neurotech LLC Electrostatic Live Cell Encapsulation Introduction
11.12.4 Neurotech LLC Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.12.5 Neurotech LLC Recent Development
11.13 LycoRed Ltd
11.13.1 LycoRed Ltd Company Detail
11.13.2 LycoRed Ltd Business Overview
11.13.3 LycoRed Ltd Electrostatic Live Cell Encapsulation Introduction
11.13.4 LycoRed Ltd Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.13.5 LycoRed Ltd Recent Development
11.14 Beta-O2 Technologies Ltd
11.14.1 Beta-O2 Technologies Ltd Company Detail
11.14.2 Beta-O2 Technologies Ltd Business Overview
11.14.3 Beta-O2 Technologies Ltd Electrostatic Live Cell Encapsulation Introduction
11.14.4 Beta-O2 Technologies Ltd Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.14.5 Beta-O2 Technologies Ltd Recent Development
11.15 DuPont
11.15.1 DuPont Company Detail
11.15.2 DuPont Business Overview
11.15.3 DuPont Electrostatic Live Cell Encapsulation Introduction
11.15.4 DuPont Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.15.5 DuPont Recent Development
11.16 Austrianova
11.16.1 Austrianova Company Detail
11.16.2 Austrianova Business Overview
11.16.3 Austrianova Electrostatic Live Cell Encapsulation Introduction
11.16.4 Austrianova Revenue in Electrostatic Live Cell Encapsulation Business (2018-2023)
11.16.5 Austrianova Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

ViaCyte
MIKROCAPS
Balchem Inc
Sernova Corp
Blacktrace Holdings Limited
Merck KGaA
B脺CHI Labortechnik AG
PharmaCyte Biotech
Living Cell Technologies Limited
Sigilon Therapeutics, Inc
Encapsys, LLC
Neurotech LLC
LycoRed Ltd
Beta-O2 Technologies Ltd
DuPont
Austrianova

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.